highperformr logo

AIM ImmunoTech's Overview

Total employees27
HeadquartersOcala
Founded

AIM ImmunoTech Inc. (NYSE American: AIM) is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19. The company's flagship products include Ampligen® (rintatolimod), a dsRNA drug approved in Argentina for severe chronic fatigue syndrome (CFS), and Alferon N Injection®, approved in the U.S. for refractory or recurring external genital warts. AIM is actively pursuing clinical trials for Ampligen in various oncology indications (e.g., pancreatic, ovarian, breast cancer) and as a potential therapeutic for Long COVID and Post-COVID Conditions.

Where is AIM ImmunoTech's Headquarters?

HQ Function

The Ocala headquarters serves as the principal executive and administrative office, overseeing research and development strategy, clinical trial management, financial operations, and corporate governance.

Notable Features:

The facility is likely a modern office space equipped to support biopharmaceutical operations, including administrative functions and coordination of external research and manufacturing.

Work Culture:

As a clinical-stage biopharmaceutical company, the work culture likely emphasizes scientific rigor, innovation, collaboration with research institutions, and a strong focus on achieving clinical milestones and regulatory approvals.

HQ Significance:

The headquarters is central to AIM ImmunoTech's strategic decision-making, investor relations, and the coordination of its global clinical development programs for its drug candidates.

Values Reflected in HQ: The headquarters' operations likely reflect the company's commitment to advancing medical science, addressing unmet patient needs, and maintaining lean operational efficiency.

Location:

While headquartered in the United States, AIM ImmunoTech has a global outlook, particularly in its clinical trial operations and drug approvals. Ampligen is approved in Argentina, and the company actively conducts or supports clinical trials in multiple countries, including sites in Europe for its oncology and Long COVID programs. Their strategy involves seeking regulatory approvals and potential commercialization partnerships in various international markets.

Street Address:

2117 SW Highway 484

City:

Ocala

State/Province:

Florida

Country:

USA

AIM ImmunoTech's Global Presence

Buying Intent Signals for AIM ImmunoTech

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of AIM ImmunoTech

As of April 2025, AIM ImmunoTech' leadership includes:

Thomas K. Equels - Chief Executive Officer and President
W. Charles Barker - Chief Financial Officer

Investors of AIM ImmunoTech

AIM ImmunoTech has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock Fund Advisors
Renaissance Technologies LLC
Geode Capital Management, LLC
State Street Global Advisors
Millennium Management LLC

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

Over the past year, AIM ImmunoTech notably strengthened its financial leadership with the appointment of W. Charles Barker as Chief Financial Officer in August 2023, succeeding the previous CFO.

Departures

Ellen K. Grassman (formerly Ellen Pravato), Ellen K. Grassman (Pravato) departed from the role of Chief Financial Officer.

New Appointments:

W. Charles Barker, W. Charles Barker was appointed as the new Chief Financial Officer.

Technology (Tech Stack) used by AIM ImmunoTech

Discover the tools AIM ImmunoTech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

AIM ImmunoTech Email Formats and Examples

AIM ImmunoTech likely uses standard corporate email formats. Common patterns include first initial followed by last name, or first name followed by last name. Given its size, simpler formats are probable.

[first_initial][last]@aimimmuno.com

Format

tequels@aimimmuno.com

Example

70%

Success rate

News and media

GlobeNewswireMay 20, 2024

AIM ImmunoTech Announces Publication of Positive Preclinical Data for Ampligen in Pancreatic Cancer Model

AIM ImmunoTech announced the publication of preclinical data in the American Journal of Cancer Research, demonstrating Ampligen's (rintatolimod) potential in treating pancreatic cancer. The study showed that Ampligen, in combination with an anti-PD-L1 checkpoint inhibitor, significantly improved T-cell infiltration and tumor regression in a murine pancreatic cancer model....more

GlobeNewswireMay 15, 2024

AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Business Update

AIM ImmunoTech reported its financial results for the first quarter ended March 31, 2024. The company highlighted progress in its clinical trials for Ampligen in pancreatic cancer and Long COVID, maintained a solid cash position, and reiterated its focus on advancing its development pipeline....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including AIM ImmunoTech, are just a search away.